Lantern Pharma Inc. (28) | Business Finance (10)

Browse by Subcategory

Recent Contracts

Description of Capital Stock (Filed With SEC on March 10, 2021)
Form of Underwriting Agreement (Filed With SEC on January 8, 2021)
Form of Amendment to Series A Preferred Stock Warrant (Filed With SEC on May 19, 2020)
Amended and Restated Investors Rights Agreement (Filed With SEC on April 16, 2020)
Assignment Agreement dated as of January 5, 2018 with BioNumerik Pharmaceuticals, Inc (Filed With SEC on April 16, 2020)
Form of Underwriting Agreement (Filed With SEC on May 19, 2020)
Specimen Stock Certificate evidencing shares of common stock (Filed With SEC on May 12, 2020)
Form of Warrant (2014) (Filed With SEC on April 16, 2020)
Form of Warrant (2017) (Filed With SEC on April 16, 2020)
Form of Warrant (2019) (Filed With SEC on April 16, 2020)